Merck Found Negligent!

As reported by the Wall Street Journal: "Merck & Co. was found negligent in the death of a 59-year-old triathlete who used Vioxx, a...

Pharma Marketing Newspeak

Although I am willing to forgive a little bit of pharma marketing BS (see "Is pharmaceutical Marketing BS?"), I am queasy about out-and-out deception,...

Alternative to DTC: cDetailing

Last week I posted what I hoped would be the beginning of a series of ideas about alternatives to DTC (see "Alternatives to DTC,...

Movies and Drugs: Same Blockbuster Mentality

You are probably aware of certain connections between Hollywood and Raritan (the nexus of Pharma's heartland); i.e., between the movie industry and the drug...

Pfizer DTC Pledge: ED is Litmus Test

Pfizer recently announced changes to its direct-to-consumer (DTC) advertising of prescription drugs (see "Pfizer Announces Improvements to Consumer Advertising for Prescription Medicines"). The Pfizer...

Internet Marketing: Risks Ahead

In an Ad Age story ("Marketers Wrestle with Hard-to-Control" Web Content") doubt is cast upon the wisdom of advertising on blogs because such consumer-controlled...

Bloggers Worry Pharma More Than FDA

Billy Tauzin, CEO of PhRMA, the US drug industry trade group, laid into the FDA's proposal for a Drug Watch site (see "FDA Drug...

Alternatives to DTC, Part 1

Recently, the following items have appeared in my radar screen: Last week I was visited by two entrepreneurs who showed...

Reminder Ads – Pharma’s Dodo?

PhRMA's New "Guiding Principle" #10 for Direct-to-Consumer Advertising states: "DTC television advertising that identifies a product by name should clearly state the health conditions...

PhRMA Finalizes DTC Principles

The US pharmaceutical trade association, PhRMA, finalized its "Guiding Principles" for TV and print direct-to-consumer (DTC) advertising yesterday (see "America’s Pharmaceutical Industry Announces Guidelines...